Result of General Meeting and Issue of Equity
Updated : 12:50
14 May 2020
Catenae Innovation PLC
("Catenae", or the "Company")
Result of General Meeting and Issue of Equity
Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that, at the General Meeting of the Company held earlier today, all resolutions were duly passed.
As a consequence, further to announcement of 20 April 2020, application will be made for the 32,000,000 new ordinary shares to be admitted to trading on AIM, which is expected to occur on or around 20 May 2020. The 32,000,000 new ordinary shares will rank pari passu with the existing ordinary shares of Catenae.
Following admission, the Company will have in issue 139,236,017 ordinary shares with voting rights. The above figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency rules.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.
- Ends -
For further information please contact:
Catenae Innovation PLC | +44 (0) 191 580 8545 |
Guy Meyer, Interim Chief Executive Officer |
|
|
|
|
|
Cairn Financial Advisers LLP (Nominated Adviser) | +44 (0)20 7213 0880 |
Liam Murray Jo Turner |
|
|
|
|
|
Brandon Hill Capital Limited (Broker) Andy Gutmann | +44 (0) 20 3463 5000 +44 (0)78796 8313
|
|
|
Yellow Jersey PR (PR & IR) | +44 (0)20 3004 9512 |
Sarah Hollins Annabel Atkins |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.